WEE1 Inhibitor MK-1775, Docetaxel, and Cisplatin Before Surgery in Treating Patients With Borderline Resectable Stage III-IVB Squamous Cell Carcinoma of the Head and Neck
Clinical trial NCT02508246 · COMPLETED
Trial details
- NCT number
- NCT02508246
- Sponsor
- University of Washington
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-22
- Primary completion
- 2018-04-26
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.